Interim results from AIR, an open-label, single arm, 36-week ph 2 trial of C21 in subjects with idiopathic pulmonary fibrosis
Autor: | T Maher, C Ganslandt, R Batta, G Tornling, T Bengtsson, H Pophale, E Rosendahl |
---|---|
Rok vydání: | 2022 |
Zdroj: | 12.01 - Idiopathic interstitial pneumonias. |
DOI: | 10.1183/13993003.congress-2022.4402 |
Databáze: | OpenAIRE |
Externí odkaz: |